“Antibody-Targeted Lipid Nanoparticles: Recent Developments, Design, and In Vivo Dynamics”

https://pubmed.ncbi.nlm.nih.gov/38117251

Antibody-targeted lipid nanoparticles are a promising advancement in precision medicine, effectively delivering various therapeutic agents, with increasing potential for industrial applications and clinical use, as detailed in this review of recent developments, design aspects, CMC considerations, and in vivo dynamics.